FamiCord AG Sustainability Reports
FamiCord AG provides biobanking services focused on the collection, preparation, processing, and long-term storage of stem cells from umbilical cord blood, cord tissue, and postnatal tissues. The company also develops advanced cellular therapies and biotech solutions for regenerative medicine and oncology applications.
Sector: Healthcare & social services
Country: Germany
Exchange: Deutsche Börse (Xetra)
LEI: 529900OEWA4GSZEZ4P40
FIGI: BBG001SM69P5
9 reports from 2020 to 2025
